Speaker Profile

PHD, Partner, Morrison Foerster

Biography
Janet focuses on worldwide patent procurement, patent portfolio management, and strategic planning for life sciences companies. Her clients range from large multinational biopharmaceutical companies, such as Celgene and Genentech, to emerging startup companies around the world. She advises her clients on patent matters relating to various technologies, including antibody therapeutics, cell therapeutics, nanomedicine, gene therapy, drug delivery systems, diagnostics, and nutraceuticals. Janet works extensively in performing IP due diligence reviews in the contexts of VC investments, technology transactions, mergers and acquisitions, and marketing and manufacturing clearance for biopharmaceutical products. She is noted for her in-depth knowledge of patent landscapes in the fields of cancer immunotherapy, gene editing, next-generation sequencing, liquid biopsy, antibody manufacturing, and medical devices.


Talk
This discussion will focus on the latest patent law developments in the field of immunotherapy including patentability issues, recent case law, and patent strategy considerations. Participants will gain insight on how to navigate the evolving case law around immunotherapies and build valuable patent portfolios in light of these new developments.


 Session Abstract – PMWC 2023 Silicon Valley

Track 1 - January 26 9.00 A.M.-4.30 P.M.


Track Chair: Sharon Benzeno, Adaptive Biotechnologies

  • PMWC 2023 Luminary Award Ceremony
    Honoree: Bruce Levine, University of Pennsylvania
  • Advance and Optimize Cell Therapies in Oncology (PANEL)
    Chair: Sharon Benzeno, Adaptive Biotechnologies
    - Ira Mellman, Genenetch
    - Mark Selby, Walking Fish Therapeutics
    - Sneha Ramakrishna, Stanford
    - Loïc VINCENT, Affini-T Therapeutics
    - Nick Haining, Arsenal
    - Warner Biddle, Kite
  • Pioneering Cell Therapies in the Treatment of Autoimmune Disorders (PANEL)
    Chair: Carl June, UPenn
    - Lenny Dragone, Sonoma
    - James Chung, Kyverna
    - David Chang, Cabaletta
    - Cristina Musselli, Abata Therapeutics
  • Innovations in Cell Therapy Manufacturing (PANEL)
    Chair: Bruce Levine, University of Pennsylvania
    - Chris Holt, BMS
    - Heidi Hagen, Sonoma Bio
    - Rahul Singhvi, Resilience
    - Snehal Patel, Sana Biotechnology
  • Patentability of Immunotherapies - Latest Developments
    - Janet Xiao, Morrison & Foerster LLP
  • Investing in Gene-Modified Cell Therapies
    Chair: Karen Tkach Tuzman, BioCentury Inc.
    - Robert Lin, UPMC
    - Yvonne Yamanaka, venBio
    - Abraham Bassan, Samsara Capital
    - Brian Daniels, 5am Ventures
  • Leveraging Data Sets to Inform Future Drug Discovery and Development (PANEL)
    Chair: Jason Coloma, Maze Therapeutics
    - Peter DiLaura, Sonoma Bio
    - Nick Haining, Arsenal
    - Kwame Okrah, Parker Institute
    - Dan Kirouac, Notch Therapeutics